A new trading day began on Friday, with Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) stock price down -6.36% from the previous day of trading, before settling in for the closing price of $0.14. TNXP’s price has ranged from $0.12 to $22.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 31.99%. With a float of $137.26 million, this company’s outstanding shares have now reached $137.26 million.
The firm has a total of 103 workers. Let’s measure their productivity. In terms of profitability, gross margin is 7.54%, operating margin of -731.49%, and the pretax margin is -1071.98%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.00%, while institutional ownership is 0.86%.
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 17.6 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -6.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.99% per share during the next fiscal year.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Here are Tonix Pharmaceuticals Holding Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.56, a number that is poised to hit -3.95 in the next quarter and is forecasted to reach -14.23 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Analysing the last 5-days average volume posted by the [Tonix Pharmaceuticals Holding Corp, TNXP], we can find that recorded value of 12.12 million was better than the volume posted last year of 10.16 million. As of the previous 9 days, the stock’s Stochastic %D was 26.30%. Additionally, its Average True Range was 0.02.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 1.57%, which indicates a significant decrease from 5.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.58% in the past 14 days, which was lower than the 136.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1493, while its 200-day Moving Average is $3.7413. Now, the first resistance to watch is $0.1380. This is followed by the second major resistance level at $0.1449. The third major resistance level sits at $0.1496. If the price goes on to break the first support level at $0.1264, it is likely to go to the next support level at $0.1217. Should the price break the second support level, the third support level stands at $0.1148.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
With a market capitalization of 22.94 million, the company has a total of 137,256K Shares Outstanding. Currently, annual sales are 7,770 K while annual income is -116,660 K. The company’s previous quarter sales were 2,210 K while its latest quarter income was -78,780 K.
